HOECHST SELDANE NOTICE OF OPPORTUNITY FOR HEARING ON WITHDRAWAL COULD PUBLISH SOON; IVAX TERFENADINE LIKELY TO BE ONLY GENERIC DURING DELIBERATIONS
Executive Summary
FDA is understood to be preparing a notice of opportunity for hearing on a proposal to withdraw Hoechst Marion Roussel's Seldane from the market for safety reasons.